Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study — Maria Pia Amato (2023) | RDL Network
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study
Article 2023 en
Authors
MA
Maria Pia Amato
RB
Roberto Bergamaschi
DC
Diego Centonze
Abstract
1 min read
Teriflunomide confirmed its real-world efficacy and was found to have a potentially beneficial effect on cognition.
Gıancarlo Comı, Timothy R. Vollmer, Xavier Montalbán, Tjalf Ziemssen, Alexey Boyко, Patrick Vermersch, Tamar Rachmilewitz, Noah J. Sasson, Tali Gorfine, Volker Knappertz, Maria A. Rocca, Massimo Filippi
Discussion(0)
No comments yet. Be the first to comment.